Press Release

View printer-friendly version << Back
Juniper Pharmaceuticals to Announce Third Quarter Financial Results on November 10, 2015

BOSTON, Oct. 28, 2015 /PRNewswire/ -- Juniper Pharmaceuticals, Inc., (Nasdaq: JNP) ("the Company") announced today it will report its third quarter 2015 financial results on Tuesday, November 10, 2015, after market close. Management will discuss the results during the Company's Investor Day on Wednesday, November 11, 2015, beginning at 10:00am ET

A live webcast of Juniper's Investor Day presentations will be available on Juniper's website under Presentations and through the following link:  

A replay of the Investor Day webcast will be available approximately two hours following completion of the event at the aforementioned URLs. The archived webcast will be available for 90 days.

About Juniper Pharmaceuticals

Juniper Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women's health.  Juniper has a commercial product,  CRINONE® 8% (progesterone gel), which is marketed by Allergan, Inc. in the U.S. and by Merck KGaA, Darmstadt, Germany, in over 90 countries worldwide. The Company is advancing a pipeline of proprietary drug candidates leveraging novel delivery technologies.  Please visit for more information.

Juniper Pharmaceuticals™ is a trademark of Juniper Pharmaceuticals, Inc., in the U.S. and EU.

CRINONE® is a registered trademark of Allergan, Inc. in the U.S. and of Merck KGaA, Darmstadt, Germany, outside the U.S.

Amy Raskopf
Director, Corporate Communications
Juniper Pharmaceuticals
(917) 673-5775

Follow us on LinkedIn.

Logo -

To view the original version on PR Newswire, visit:

SOURCE Juniper Pharmaceuticals, Inc.